NIH Funding Opportunities

Subscribe to NIH Funding Opportunities feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 16 min 34 sec ago

Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

6 hours 32 min ago
Funding Opportunity PAR-19-104 from the NIH Guide for Grants and Contracts. As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. Whole genome, exome, and transcriptome sequencing may be available for tumor or affected tissue when justified. These data will become part of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource) for the pediatric research community.
Categories: Science RSS Feeds

Contraception Research Centers Program (U54 Clinical Trial Optional)

13 hours 46 min ago
Funding Opportunity RFA-HD-19-023 from the NIH Guide for Grants and Contracts. The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success, and also behavioral and social science research projects to study contraceptive use and non-use of marketed products or products in clinical development. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Categories: Science RSS Feeds

Notice of NINDS' Participation in NOT-AG-18-050 "Notice to Specify High-Priority Research Topic for PAR-19-070"

Thu, 12/13/2018 - 11:29
Notice NOT-NS-19-025 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Notice of Pre-Application Webinars for the HEAL Initiative: Back Pain Consortium (BACPAC) Research Program

Thu, 12/13/2018 - 11:22
Notice NOT-AR-19-031 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Notice of Expiration of PA-18-475 " Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed)"

Wed, 12/12/2018 - 11:01
Notice NOT-NR-18-024 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Notice of Expiration of PA-18-471 "Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed)"

Wed, 12/12/2018 - 10:34
Notice NOT-NR-18-022 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Advance Notice: Streamlining the Certifications and Representations Process and Phasing out the SF-424B

Wed, 12/12/2018 - 10:15
Notice NOT-OD-19-043 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed)

Wed, 12/12/2018 - 10:10
Funding Opportunity RFA-DE-19-007 from the NIH Guide for Grants and Contracts. The purpose of the program is to support mentoring and research education activities that enhance the diversity of the NIDCR research workforce by establishing long-term mentoring that will enable junior investigators who are underrepresented in the biomedical, behavioral and clinical sciences to develop a research program and obtain NIDCR funding
Categories: Science RSS Feeds

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Wed, 12/12/2018 - 10:10
Funding Opportunity PAR-19-100 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from two or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA. The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, and collaborative research projects in the CTSA Program, with the goal of assessing utility and feasibility of proposed innovation(s).
Categories: Science RSS Feeds

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)

Wed, 12/12/2018 - 10:10
Funding Opportunity PAR-19-099 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from three or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA.
Categories: Science RSS Feeds

Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)

Wed, 12/12/2018 - 09:27
Funding Opportunity PAR-19-102 from the NIH Guide for Grants and Contracts. The goal of the Graduate Research Initiative for Student Enhancement (G-RISE) program is to develop a diverse pool of scientists earning a Ph.D., who have the skills to successfully transition into careers in the biomedical research workforce. This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. This program is limited to applications from training programs at research-active institutions (i.e., those with a 3-year average of NIH Research Project Grant funding less than $7.5 million total costs).
Categories: Science RSS Feeds

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

Wed, 12/12/2018 - 09:07
Funding Opportunity PAR-19-101 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U01 cooperative agreement applications for Physical Science-Oncology Projects (PS-OP). The goal of the PS-OPs is to foster the convergence of physical sciences approaches and perspectives with cancer research to advance our understanding of cancer biology and oncology by forming small transdisciplinary teams of physical scientists and cancer biologists/physician-scientists. Examples of physical scientists may include engineers, physicists, mathematicians, chemists, and computer scientists. The PS-OPs, individually and as a collaborative Network along with other PS-OPs and the Physical Sciences-Oncology Centers (PS-OC), will support transdisciplinary research that: (1) establishes a physical sciences perspective within the cancer research community; (2) facilitates team science and field convergence at the intersection of physical sciences and cancer research; and (3) collectively tests physical sciences-based experimental and theoretical concepts of cancer and promotes innovative solutions to address outstanding questions in cancer research.
Categories: Science RSS Feeds

Notice of Intent to Publish a Funding Opportunity Announcement for Administrative Supplements for Research on Bioethical Issues

Wed, 12/12/2018 - 08:14
Notice NOT-OD-19-045 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to PA-18-705

Wed, 12/12/2018 - 07:58
Notice NOT-NS-19-023 from the NIH Guide for Grants and Contracts
Categories: Science RSS Feeds

Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)

Tue, 12/11/2018 - 11:14
Funding Opportunity RFA-NS-19-014 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports the development of PET radioligands that identify proteinopathies or pathological processes associated with the human biology of Alzheimer's disease related dementias (ADRDs). Activities supported under this FOA include, but are not limited to the in vitro screening of existing ligands against human ADRD brain tissue, medicinal chemistry support for development of new compounds and improvement of existing ligand specificity and selectivity, initial screening of ligands in appropriate animal models, and radioligand formulation and first-in-human testing. The Center without Walls should encompass research that will move promising ligands through in vitro and in vivo optimization to first-in-human studies. Applications must include an administrative core, a medicinal chemistry core, a clinical core, a scientific governance structure, and a minimum of two research projects with milestone plans that address workflows for screening of existing and newly derived ligands against human ADRD tissue and appropriate animal models. Synergy must be evident among Center research projects and cores, such that successful completion of the aims could not be accomplished without the Center structure. This FOA is in response to the Alzheimer's Disease Related Dementias (ADRD) challenges outlined in the 2016 update to the National Plan to Address Alzheimer's Disease.
Categories: Science RSS Feeds

Pages